HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 241 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q4 2022. The put-call ratio across all filers is 1.21 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,572 | -33.7% | 292,100 | -28.8% | 0.02% | -23.8% |
| Q2 2023 | $14,442 | -5.0% | 410,400 | -11.9% | 0.02% | +5.0% |
| Q1 2023 | $15,208 | -19.5% | 465,800 | +35.9% | 0.02% | -23.1% |
| Q4 2022 | $18,883 | -99.9% | 342,700 | +5.4% | 0.03% | +30.0% |
| Q3 2022 | $14,394,000 | +1.1% | 325,000 | +11.4% | 0.02% | +17.6% |
| Q2 2022 | $14,231,000 | +105.3% | 291,800 | +104.8% | 0.02% | +112.5% |
| Q1 2022 | $6,933,000 | +20.6% | 142,500 | +5.7% | 0.01% | +14.3% |
| Q4 2021 | $5,748,000 | +280.7% | 134,800 | +242.1% | 0.01% | +250.0% |
| Q3 2021 | $1,510,000 | +353.5% | 39,400 | +233.9% | 0.00% | – |
| Q2 2021 | $333,000 | – | 11,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $366,268,777 | 96.46% |
| venBio Partners LLC | 1,035,396 | $33,805,679 | 18.74% |
| Nan Fung Group Holdings Ltd | 368,665 | $12,036,912 | 8.19% |
| Vivo Capital, LLC | 2,606,247 | $85,093,965 | 5.90% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 570,500 | $18,621,120 | 5.20% |
| ASHFORD CAPITAL MANAGEMENT INC | 445,418 | $14,542,898 | 2.18% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 678,715 | $22,160,045 | 2.07% |
| TANG CAPITAL MANAGEMENT LLC | 321,200 | $10,487,180 | 1.56% |
| AlphaCentric Advisors LLC | 67,500 | $2,203,875 | 1.52% |
| Paradiem, LLC | 66,995 | $2,187,387 | 0.68% |